Rajany Vidallon Dy, MD
NPI 1316226665ActiveIndividual· Internal Medicine, Pulmonary Disease· Palo Alto, CA
Internal Medicine, Pulmonary Disease (MD) in Palo Alto, California, licensed in CA and NV, with an NPI issued in August 2011. Their prescriptions cost Medicare Part D more than their services did: $10,954 for 57 claims, against $2,029 paid for services in 2024. Actelion Pharmaceuticals US, Inc. was the largest of 5 companies reporting payments in 2025, $850.80 in all, mostly food and beverage.
Overview
| NPI | 1316226665 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | No |
| NPI issued | Aug 4, 2011 |
| Last updated in NPPES | Apr 29, 2024 |
| Certified by provider | Apr 29, 2024 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Pulmonary Disease Primary | 207RP1001X | A144033 | CA |
| Internal Medicine | 207R00000X | A144033 | CA |
| Internal Medicine, Critical Care Medicine | 207RC0200X | A144033 | CA |
| Internal Medicine, Pulmonary Disease | 207RP1001X | 17667 | NV |
| Student in an Organized Health Care Education/Training Program | 390200000X | — | — |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 10, 2026 | No match | — |
| New York OMIG · Nov 10, 2026 | No match | — |
| Ohio Medicaid · Nov 10, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 10, 2026 | No match | — |
| Washington HCA · Nov 10, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Order and Referring Only - Pulmonary Disease (CA) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 18 |
|---|---|
| Services billed | 18 across 3 procedure codes |
| Paid by Medicare | $2,029 |
Part D prescriptions in 2024
| Prescriptions (claims) | 57 · 98 30-day fills |
|---|---|
| Patients | 15 |
| Total drug cost | $10,954 |
| Generic share | 68% of claims |
Industry payments (Open Payments)
- 2025$850.80 · 23 payments from 5 companies
- 2024$305.37 · 11 payments from 4 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | $307.57 | 8 |
| Bayer Healthcare Pharmaceuticals Inc. | $234.75 | 2 |
| Merck Sharp & Dohme LLC | $205.47 | 9 |
| United Therapeutics Corporation | $71.34 | 3 |
| Liquidia Technologies, Inc. | $31.67 | 1 |
What the 2025 payments were for
- Food and Beverage$560.11 · 20 payments
- Consulting Fee$200.00 · 1 payment
- Education$90.69 · 2 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Pulmonary Disease providers in Palo Alto
- 1477646313
- 1407389984
- 1619437258
- 1922421569
- 1043321581
- 1114075439
- 1811057086
- 1336859842
- 1487665964
- 1861504003
- 1174542161
- 1205367356
All Internal Medicine, Pulmonary Disease providers in California →